IHS Chemical Week

Regions :: Western Europe :: U.K.

CPhI: Aesica to triple API sales in three years, to acquire assets in North America and India next year

8:18 AM MDT | October 11, 2012 | Deepti Ramesh in Madrid

Aesica Pharmaceuticals (Newcastle, UK), a provider of active pharmaceutical ingredients (APIs), formulations, and custom synthesis, says that it plans to triple annual revenues from the company’s API business by 2015. Aesica recorded total sales of about $250 million in 2011 and the company’s API business has annual sales of about $50 million. “We have a focused plan to increase the annual API revenues to at least $150 million by the end of 2015, and this will be through a mix of organic and inorganic growth,” Kevin Cook, managing...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa